SUPERSONIC SHEARWAVE ELASTOGRAPHY OF RESPONSE TO ANTI-CANCER THERAPY IN A XENOGRAFT TUMOR MODEL

被引:18
|
作者
Chamming's, Foucauld [1 ,2 ]
Le-Frere-Belda, Marie-Aude [3 ]
Latorre-Ossa, Heldmuth [4 ]
Fitoussi, Victor [1 ]
Redheuil, Alban [2 ]
Assayag, Franck [5 ]
Pidial, Laetitia [1 ]
Gennisson, Jean-Luc [4 ]
Tanter, Mickael [4 ]
Cuenod, Charles-Andre [1 ,2 ]
Fournier, Laure S. [1 ,2 ]
机构
[1] Univ Paris 05, Sorbonne Paris Cite, UMR S970, Cardiovasc Res Ctr PARCC, Paris, France
[2] Univ Paris 05, Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Dept Radiol,Sorbonne Paris Cite, Paris, France
[3] Univ Paris 05, Hop Europeen Georges Pompidou, Assistance Publ Hop Paris, Dept Pathol,Sorbonne Paris Cite, Paris, France
[4] Ecole Super Phys & Chim Ind Ville Paris, Inst Langevin Ondes & Images, Paris, France
[5] INSERM, U612, Pharmacol Preclin Antitumorale, Paris, France
来源
ULTRASOUND IN MEDICINE AND BIOLOGY | 2016年 / 42卷 / 04期
关键词
Shear wave elastography; Ultrasound; Stiffness changes; Breast cancer; Response to therapy; Pathology; ADVANCED BREAST-CANCER; NEOADJUVANT CHEMOTHERAPY; WAVE ELASTOGRAPHY; ULTRASOUND ELASTOGRAPHY; PATHOLOGICAL RESPONSE; CLINICAL-APPLICATION; EARLY PREDICTION; BIOMARKERS; CARCINOMA; DIAGNOSIS;
D O I
10.1016/j.ultrasmedbio.2015.12.001
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
Our objective was to determine if supersonic shear wave elastography (SSWE) can detect changes in stiffness of a breast cancer model under therapy. A human invasive carcinoma was implanted in 22 mice. Eleven were treated with an anti-angiogenic therapy and 11 with glucose for 24 d. Tumor volume and stiffness were assessed during 2 wk before treatment and 0, 7, 12, 20 and 24 d after the start of therapy using SSWE. Pathology was assessed after 12 and 24 d of treatment. We found that response to therapy was associated with early softening of treated tumors only, resulting in a significant difference from non-treated tumors after 12 d of treatment (p = 0.03). On pathology, large areas of necrosis were observed at 12 d in treated tumors. Although treatment was still effective, treated tumors subsequently stiffened during a second phase of the treatment (days 12-24), with a small amount of necrosis observed on pathology on day 24. In conclusion, SSWE was able to measure changes in the stiffness of tumors in response to anti-cancer treatment. However, stiffness changes associated with good response to treatment may change over time, and increased stiffness may also reflect therapy efficacy. (E-mail: foucauld.chammings@egp.aphp.fr) (C) 2016 World Federation for Ultrasound in Medicine & Biology.
引用
收藏
页码:924 / 930
页数:7
相关论文
共 50 条
  • [1] A novel zebrafish human tumor xenograft model validated for anti-cancer drug screening
    Jung, Da-Woon
    Oh, Eun-Sang
    Park, Si-Hwan
    Chang, Young-Tae
    Kim, Cheol-Hee
    Choi, Seok-Yong
    Williams, Darren R.
    MOLECULAR BIOSYSTEMS, 2012, 8 (07) : 1930 - 1939
  • [2] Anti-cancer effects of docetaxel loaded thermo-reversible hydrogels in a tumor xenograft mice model
    Kim, Jang-Kyoung
    Won, Young-Wook
    Lim, Kwang Suk
    Park, Eun Jeong
    Kim, Yong-Hee
    JOURNAL OF CONTROLLED RELEASE, 2011, 152 : E44 - E45
  • [3] Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
    Bagby, Stacey
    Messersmith, Wells A.
    Pitts, Todd M.
    Capasso, Anna
    Varella-Garcia, Marileila
    Klauck, Peter J.
    Kim, Jihye
    Tan, Aik-Choon
    Eckhardt, S. Gail
    Tentler, John J.
    Arcaroli, John
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2016, (115):
  • [4] Signal Transduction and Response to Anti-Cancer Therapy
    Skvortsova, Ira-Ida
    CURRENT SIGNAL TRANSDUCTION THERAPY, 2012, 7 (03) : 185 - 186
  • [5] Intracellular Signaling and Response to Anti-Cancer Therapy
    Skyortsova, Ira
    SEMINARS IN CANCER BIOLOGY, 2015, 31 : 1 - 2
  • [6] Targeting tumor associated macrophages for anti-cancer therapy
    Guerriero, Jennifer L.
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (01)
  • [7] Metronomic Anti-Cancer Therapy: A Multimodal Therapy Governed by the Tumor Microenvironment
    Munoz, Raquel
    Girotti, Alessandra
    Hileeto, Denise
    Arias, Francisco Javier
    CANCERS, 2021, 13 (21)
  • [8] Microcrater-Arrayed Chemiluminescence Cell Chip to Boost Anti-Cancer Drug Administration in Zebrafish Tumor Xenograft Model
    Kuo, Ching-Te
    Lai, Yu-Sheng
    Lu, Siang-Rong
    Lee, Hsinyu
    Chang, Hsiu-Hao
    BIOLOGY-BASEL, 2022, 11 (01):
  • [9] Tumor-targeted Nanobullets for Anti-cancer Combination Therapy
    van der Meel, R.
    Oliveira, S.
    Altintas, I.
    Haselberg, R.
    Roovers, R. C.
    van Bergen en Henegouwen, P. M. P.
    Hennink, W. E.
    Storm, W. E.
    Schiffelers, R. M.
    Kok, R. J.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : 38 - 38
  • [10] Impact of Tumor and Immunological Heterogeneity on the Anti-Cancer Immune Response
    Shembrey, Carolyn
    Huntington, Nicholas D.
    Hollande, Frederic
    CANCERS, 2019, 11 (09)